nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—CPT1A—breast cancer	0.189	0.502	CbGaD
Glyburide—ABCC1—breast cancer	0.0839	0.222	CbGaD
Glyburide—ABCG2—breast cancer	0.0442	0.117	CbGaD
Glyburide—ABCC1—Idarubicin—breast cancer	0.0229	0.0589	CbGbCtD
Glyburide—CYP3A4—breast cancer	0.0221	0.0586	CbGaD
Glyburide—SLCO1A2—Chlorambucil—breast cancer	0.0204	0.0525	CbGbCtD
Glyburide—ALB—breast cancer	0.0193	0.0511	CbGaD
Glyburide—ABCB1—breast cancer	0.0184	0.0488	CbGaD
Glyburide—ABCB11—Tamoxifen—breast cancer	0.0142	0.0365	CbGbCtD
Glyburide—ABCC3—Fluorouracil—breast cancer	0.0121	0.0311	CbGbCtD
Glyburide—ABCB11—Paclitaxel—breast cancer	0.011	0.0284	CbGbCtD
Glyburide—CFTR—sweat gland—breast cancer	0.0102	0.232	CbGeAlD
Glyburide—ABCC1—Mitoxantrone—breast cancer	0.00983	0.0253	CbGbCtD
Glyburide—ABCB11—Vinblastine—breast cancer	0.00968	0.0249	CbGbCtD
Glyburide—SLC22A7—Fluorouracil—breast cancer	0.00945	0.0243	CbGbCtD
Glyburide—ABCC1—Epirubicin—breast cancer	0.00795	0.0205	CbGbCtD
Glyburide—ABCC1—Paclitaxel—breast cancer	0.00784	0.0202	CbGbCtD
Glyburide—ABCC1—Irinotecan—breast cancer	0.00774	0.0199	CbGbCtD
Glyburide—CYP2C9—Anastrozole—breast cancer	0.0075	0.0193	CbGbCtD
Glyburide—ABCC2—Tamoxifen—breast cancer	0.00746	0.0192	CbGbCtD
Glyburide—SLC22A7—Docetaxel—breast cancer	0.00722	0.0186	CbGbCtD
Glyburide—ABCC3—Doxorubicin—breast cancer	0.00688	0.0177	CbGbCtD
Glyburide—ABCC1—Vinblastine—breast cancer	0.00688	0.0177	CbGbCtD
Glyburide—ABCG2—Tamoxifen—breast cancer	0.00674	0.0174	CbGbCtD
Glyburide—ABCC3—Methotrexate—breast cancer	0.00667	0.0172	CbGbCtD
Glyburide—ABCB1—Toremifene—breast cancer	0.00665	0.0171	CbGbCtD
Glyburide—ABCG2—Mitoxantrone—breast cancer	0.00658	0.0169	CbGbCtD
Glyburide—CYP2C19—Lapatinib—breast cancer	0.00602	0.0155	CbGbCtD
Glyburide—ABCB11—Doxorubicin—breast cancer	0.00595	0.0153	CbGbCtD
Glyburide—ABCC2—Paclitaxel—breast cancer	0.0058	0.0149	CbGbCtD
Glyburide—CYP3A4—Exemestane—breast cancer	0.00575	0.0148	CbGbCtD
Glyburide—ABCC2—Irinotecan—breast cancer	0.00573	0.0147	CbGbCtD
Glyburide—CYP2C9—Idarubicin—breast cancer	0.00568	0.0146	CbGbCtD
Glyburide—ABCC1—Docetaxel—breast cancer	0.00567	0.0146	CbGbCtD
Glyburide—ABCC2—Carboplatin—breast cancer	0.00546	0.0141	CbGbCtD
Glyburide—ABCG2—Paclitaxel—breast cancer	0.00525	0.0135	CbGbCtD
Glyburide—SLC22A7—Methotrexate—breast cancer	0.00521	0.0134	CbGbCtD
Glyburide—ABCG2—Irinotecan—breast cancer	0.00518	0.0133	CbGbCtD
Glyburide—ABCC2—Vinblastine—breast cancer	0.00509	0.0131	CbGbCtD
Glyburide—ABCG2—Fluorouracil—breast cancer	0.00497	0.0128	CbGbCtD
Glyburide—ABCG2—Carboplatin—breast cancer	0.00494	0.0127	CbGbCtD
Glyburide—CYP3A4—Letrozole—breast cancer	0.00489	0.0126	CbGbCtD
Glyburide—ABCB1—Lapatinib—breast cancer	0.00485	0.0125	CbGbCtD
Glyburide—CYP3A4—Anastrozole—breast cancer	0.00436	0.0112	CbGbCtD
Glyburide—ABCC1—Doxorubicin—breast cancer	0.00423	0.0109	CbGbCtD
Glyburide—ABCC2—Docetaxel—breast cancer	0.0042	0.0108	CbGbCtD
Glyburide—ABCC1—Methotrexate—breast cancer	0.00409	0.0105	CbGbCtD
Glyburide—CYP3A4—Toremifene—breast cancer	0.00399	0.0103	CbGbCtD
Glyburide—ABCG2—Docetaxel—breast cancer	0.00379	0.00977	CbGbCtD
Glyburide—CYP3A4—Fulvestrant—breast cancer	0.00371	0.00955	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—breast cancer	0.00366	0.00941	CbGbCtD
Glyburide—ALB—Irinotecan—breast cancer	0.00357	0.00919	CbGbCtD
Glyburide—ALB—Fluorouracil—breast cancer	0.00342	0.00882	CbGbCtD
Glyburide—CYP3A4—Thiotepa—breast cancer	0.0033	0.00851	CbGbCtD
Glyburide—ABCC2—Doxorubicin—breast cancer	0.00313	0.00806	CbGbCtD
Glyburide—CYP2C9—Capecitabine—breast cancer	0.00311	0.00802	CbGbCtD
Glyburide—ABCC2—Methotrexate—breast cancer	0.00303	0.0078	CbGbCtD
Glyburide—CYP3A4—Ixabepilone—breast cancer	0.00302	0.00778	CbGbCtD
Glyburide—CYP2C19—Tamoxifen—breast cancer	0.00301	0.00776	CbGbCtD
Glyburide—CYP3A4—Lapatinib—breast cancer	0.00291	0.00749	CbGbCtD
Glyburide—ABCG2—Doxorubicin—breast cancer	0.00283	0.00728	CbGbCtD
Glyburide—ABCG2—Methotrexate—breast cancer	0.00274	0.00706	CbGbCtD
Glyburide—ABCB1—Vinorelbine—breast cancer	0.00269	0.00694	CbGbCtD
Glyburide—CYP2C9—Tamoxifen—breast cancer	0.0025	0.00645	CbGbCtD
Glyburide—ABCB1—Tamoxifen—breast cancer	0.00243	0.00626	CbGbCtD
Glyburide—ABCB1—Mitoxantrone—breast cancer	0.00237	0.00611	CbGbCtD
Glyburide—SLC22A6—Methotrexate—breast cancer	0.00222	0.00571	CbGbCtD
Glyburide—CYP3A4—Raloxifene—breast cancer	0.0022	0.00568	CbGbCtD
Glyburide—ABCB1—Gemcitabine—breast cancer	0.00209	0.00539	CbGbCtD
Glyburide—CYP2C9—Paclitaxel—breast cancer	0.00195	0.00502	CbGbCtD
Glyburide—ABCB1—Paclitaxel—breast cancer	0.00189	0.00487	CbGbCtD
Glyburide—ALB—Methotrexate—breast cancer	0.00189	0.00486	CbGbCtD
Glyburide—ABCB1—Irinotecan—breast cancer	0.00187	0.00481	CbGbCtD
Glyburide—CYP2C9—Fluorouracil—breast cancer	0.00185	0.00475	CbGbCtD
Glyburide—ABCC9—mammary gland—breast cancer	0.00179	0.041	CbGeAlD
Glyburide—ABCB1—Vinblastine—breast cancer	0.00166	0.00427	CbGbCtD
Glyburide—CYP3A4—Vinorelbine—breast cancer	0.00161	0.00416	CbGbCtD
Glyburide—CYP3A4—Tamoxifen—breast cancer	0.00146	0.00375	CbGbCtD
Glyburide—CYP3A4—Mitoxantrone—breast cancer	0.00142	0.00366	CbGbCtD
Glyburide—ABCB1—Docetaxel—breast cancer	0.00137	0.00352	CbGbCtD
Glyburide—ABCA1—mammary gland—breast cancer	0.00122	0.0278	CbGeAlD
Glyburide—CYP3A4—Paclitaxel—breast cancer	0.00113	0.00292	CbGbCtD
Glyburide—CYP3A4—Irinotecan—breast cancer	0.00112	0.00288	CbGbCtD
Glyburide—KCNJ5—pituitary gland—breast cancer	0.00107	0.0244	CbGeAlD
Glyburide—ABCB1—Doxorubicin—breast cancer	0.00102	0.00263	CbGbCtD
Glyburide—CYP3A4—Vinblastine—breast cancer	0.000994	0.00256	CbGbCtD
Glyburide—ABCB1—Methotrexate—breast cancer	0.000988	0.00254	CbGbCtD
Glyburide—KCNJ5—adrenal gland—breast cancer	0.000956	0.0218	CbGeAlD
Glyburide—KCNJ5—endocrine gland—breast cancer	0.000829	0.0189	CbGeAlD
Glyburide—CYP3A4—Docetaxel—breast cancer	0.00082	0.00211	CbGbCtD
Glyburide—ABCC9—adipose tissue—breast cancer	0.000807	0.0184	CbGeAlD
Glyburide—KCNJ11—mammary gland—breast cancer	0.000775	0.0177	CbGeAlD
Glyburide—ABCC9—adrenal gland—breast cancer	0.000724	0.0165	CbGeAlD
Glyburide—ABCC8—mammary gland—breast cancer	0.000714	0.0163	CbGeAlD
Glyburide—ABCC9—female gonad—breast cancer	0.000675	0.0154	CbGeAlD
Glyburide—ABCA1—skin of body—breast cancer	0.000644	0.0147	CbGeAlD
Glyburide—CFTR—epithelium—breast cancer	0.00064	0.0146	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—breast cancer	0.000611	0.00157	CbGbCtD
Glyburide—CPT1A—adipose tissue—breast cancer	0.000587	0.0134	CbGeAlD
Glyburide—SLCO2B1—mammary gland—breast cancer	0.000559	0.0128	CbGeAlD
Glyburide—ABCA1—adipose tissue—breast cancer	0.000547	0.0125	CbGeAlD
Glyburide—CPT1A—female reproductive system—breast cancer	0.00054	0.0123	CbGeAlD
Glyburide—CPT1A—adrenal gland—breast cancer	0.000527	0.012	CbGeAlD
Glyburide—ALB—mammary gland—breast cancer	0.000511	0.0117	CbGeAlD
Glyburide—ABCA1—female reproductive system—breast cancer	0.000503	0.0115	CbGeAlD
Glyburide—CPT1A—female gonad—breast cancer	0.000491	0.0112	CbGeAlD
Glyburide—ABCA1—adrenal gland—breast cancer	0.000491	0.0112	CbGeAlD
Glyburide—CFTR—female reproductive system—breast cancer	0.000475	0.0109	CbGeAlD
Glyburide—ABCA1—female gonad—breast cancer	0.000458	0.0105	CbGeAlD
Glyburide—CPT1A—endocrine gland—breast cancer	0.000457	0.0104	CbGeAlD
Glyburide—ABCC9—lymph node—breast cancer	0.000434	0.00991	CbGeAlD
Glyburide—CFTR—female gonad—breast cancer	0.000432	0.00987	CbGeAlD
Glyburide—SLC15A2—mammary gland—breast cancer	0.000427	0.00975	CbGeAlD
Glyburide—ABCA1—endocrine gland—breast cancer	0.000426	0.00972	CbGeAlD
Glyburide—CFTR—endocrine gland—breast cancer	0.000402	0.00918	CbGeAlD
Glyburide—Sulpiride—CA9—breast cancer	0.000393	0.162	CrCbGaD
Glyburide—SLC15A1—epithelium—breast cancer	0.00038	0.00868	CbGeAlD
Glyburide—ABCC8—endometrium—breast cancer	0.000357	0.00814	CbGeAlD
Glyburide—ABCC1—nipple—breast cancer	0.000349	0.00797	CbGeAlD
Glyburide—SLC15A1—endometrium—breast cancer	0.000341	0.00779	CbGeAlD
Glyburide—ABCB11—endocrine gland—breast cancer	0.00033	0.00753	CbGeAlD
Glyburide—Bezafibrate—SLCO1B1—breast cancer	0.00033	0.136	CrCbGaD
Glyburide—ABCC8—pituitary gland—breast cancer	0.000323	0.00737	CbGeAlD
Glyburide—KCNJ11—female reproductive system—breast cancer	0.000321	0.00732	CbGeAlD
Glyburide—CYP2C9—mammary gland—breast cancer	0.000319	0.00729	CbGeAlD
Glyburide—CPT1A—lymph node—breast cancer	0.000316	0.00721	CbGeAlD
Glyburide—KCNJ11—adrenal gland—breast cancer	0.000313	0.00715	CbGeAlD
Glyburide—SLC22A7—endocrine gland—breast cancer	0.000297	0.00679	CbGeAlD
Glyburide—Gliclazide—VEGFA—breast cancer	0.000297	0.122	CrCbGaD
Glyburide—ABCA1—lymph node—breast cancer	0.000294	0.00672	CbGeAlD
Glyburide—KCNJ11—female gonad—breast cancer	0.000292	0.00666	CbGeAlD
Glyburide—ABCC8—adrenal gland—breast cancer	0.000288	0.00658	CbGeAlD
Glyburide—KCNJ11—endocrine gland—breast cancer	0.000271	0.0062	CbGeAlD
Glyburide—ABCC3—adipose tissue—breast cancer	0.00027	0.00616	CbGeAlD
Glyburide—SLCO2B1—uterus—breast cancer	0.000257	0.00587	CbGeAlD
Glyburide—SLCO2B1—adipose tissue—breast cancer	0.000252	0.00574	CbGeAlD
Glyburide—ABCC8—endocrine gland—breast cancer	0.00025	0.00571	CbGeAlD
Glyburide—ABCC3—female reproductive system—breast cancer	0.000248	0.00566	CbGeAlD
Glyburide—ABCC3—adrenal gland—breast cancer	0.000242	0.00553	CbGeAlD
Glyburide—Sulpiride—BCHE—breast cancer	0.000241	0.0992	CrCbGaD
Glyburide—SLC15A1—endocrine gland—breast cancer	0.000239	0.00546	CbGeAlD
Glyburide—SLCO2B1—female reproductive system—breast cancer	0.000231	0.00528	CbGeAlD
Glyburide—ABCC3—female gonad—breast cancer	0.000226	0.00515	CbGeAlD
Glyburide—SLCO2B1—adrenal gland—breast cancer	0.000226	0.00515	CbGeAlD
Glyburide—SLC15A2—endometrium—breast cancer	0.000213	0.00487	CbGeAlD
Glyburide—Zafirlukast—ABCG2—breast cancer	0.000212	0.0875	CrCbGaD
Glyburide—ABCC1—endometrium—breast cancer	0.000211	0.00481	CbGeAlD
Glyburide—SLCO2B1—female gonad—breast cancer	0.00021	0.0048	CbGeAlD
Glyburide—ABCC3—endocrine gland—breast cancer	0.00021	0.00479	CbGeAlD
Glyburide—ALB—adrenal gland—breast cancer	0.000206	0.00471	CbGeAlD
Glyburide—ABCC2—female reproductive system—breast cancer	0.000198	0.00453	CbGeAlD
Glyburide—SLCO2B1—endocrine gland—breast cancer	0.000196	0.00447	CbGeAlD
Glyburide—ABCC1—uterus—breast cancer	0.000194	0.00444	CbGeAlD
Glyburide—ABCC2—adrenal gland—breast cancer	0.000193	0.00442	CbGeAlD
Glyburide—SLC15A2—pituitary gland—breast cancer	0.000193	0.0044	CbGeAlD
Glyburide—ABCC1—pituitary gland—breast cancer	0.000191	0.00436	CbGeAlD
Glyburide—ABCC1—adipose tissue—breast cancer	0.00019	0.00434	CbGeAlD
Glyburide—KCNJ11—lymph node—breast cancer	0.000188	0.00428	CbGeAlD
Glyburide—Zafirlukast—PTGS1—breast cancer	0.000182	0.0749	CrCbGaD
Glyburide—SLCO1A2—endocrine gland—breast cancer	0.00018	0.00411	CbGeAlD
Glyburide—SLC15A2—female reproductive system—breast cancer	0.000177	0.00403	CbGeAlD
Glyburide—ABCG2—endometrium—breast cancer	0.000175	0.00398	CbGeAlD
Glyburide—SLC15A2—adrenal gland—breast cancer	0.000172	0.00393	CbGeAlD
Glyburide—ABCC1—adrenal gland—breast cancer	0.00017	0.00389	CbGeAlD
Glyburide—ABCC2—endocrine gland—breast cancer	0.000168	0.00383	CbGeAlD
Glyburide—ABCG2—uterus—breast cancer	0.000161	0.00367	CbGeAlD
Glyburide—SLC15A2—female gonad—breast cancer	0.000161	0.00367	CbGeAlD
Glyburide—ABCC1—female gonad—breast cancer	0.000159	0.00363	CbGeAlD
Glyburide—ABCG2—pituitary gland—breast cancer	0.000158	0.00361	CbGeAlD
Glyburide—ABCG2—adipose tissue—breast cancer	0.000157	0.00359	CbGeAlD
Glyburide—SLC15A2—endocrine gland—breast cancer	0.000149	0.00341	CbGeAlD
Glyburide—ABCC3—lymph node—breast cancer	0.000145	0.00331	CbGeAlD
Glyburide—CYP2C19—endocrine gland—breast cancer	0.000144	0.00329	CbGeAlD
Glyburide—ABCG2—adrenal gland—breast cancer	0.000141	0.00322	CbGeAlD
Glyburide—ABCG2—bone marrow—breast cancer	0.000136	0.00312	CbGeAlD
Glyburide—SLCO2B1—lymph node—breast cancer	0.000135	0.00309	CbGeAlD
Glyburide—CYP2C9—female reproductive system—breast cancer	0.000132	0.00302	CbGeAlD
Glyburide—ABCG2—female gonad—breast cancer	0.000132	0.003	CbGeAlD
Glyburide—Zafirlukast—CYP2D6—breast cancer	0.000124	0.051	CrCbGaD
Glyburide—ALB—lymph node—breast cancer	0.000124	0.00283	CbGeAlD
Glyburide—Chlorpropamide—PTGS1—breast cancer	0.000122	0.0501	CrCbGaD
Glyburide—ABCB1—embryo—breast cancer	0.000118	0.00269	CbGeAlD
Glyburide—ABCC2—lymph node—breast cancer	0.000116	0.00265	CbGeAlD
Glyburide—Bezafibrate—CYP1A1—breast cancer	0.000112	0.0463	CrCbGaD
Glyburide—CYP2C9—endocrine gland—breast cancer	0.000112	0.00255	CbGeAlD
Glyburide—Zafirlukast—CYP3A4—breast cancer	0.000106	0.0437	CrCbGaD
Glyburide—SLC15A2—lymph node—breast cancer	0.000103	0.00236	CbGeAlD
Glyburide—ABCC1—lymph node—breast cancer	0.000102	0.00233	CbGeAlD
Glyburide—CYP3A4—female reproductive system—breast cancer	0.000101	0.0023	CbGeAlD
Glyburide—Glipizide—CYP3A4—breast cancer	9.83e-05	0.0405	CrCbGaD
Glyburide—ABCB1—epithelium—breast cancer	9.6e-05	0.00219	CbGeAlD
Glyburide—ABCB1—endometrium—breast cancer	8.61e-05	0.00196	CbGeAlD
Glyburide—CYP3A4—endocrine gland—breast cancer	8.52e-05	0.00195	CbGeAlD
Glyburide—ABCG2—lymph node—breast cancer	8.46e-05	0.00193	CbGeAlD
Glyburide—Gliclazide—ALB—breast cancer	7.97e-05	0.0328	CrCbGaD
Glyburide—ABCB1—uterus—breast cancer	7.93e-05	0.00181	CbGeAlD
Glyburide—ABCB1—pituitary gland—breast cancer	7.79e-05	0.00178	CbGeAlD
Glyburide—ABCB1—adipose tissue—breast cancer	7.76e-05	0.00177	CbGeAlD
Glyburide—Bezafibrate—CYP3A4—breast cancer	7.17e-05	0.0295	CrCbGaD
Glyburide—ABCB1—female reproductive system—breast cancer	7.13e-05	0.00163	CbGeAlD
Glyburide—ABCB1—adrenal gland—breast cancer	6.96e-05	0.00159	CbGeAlD
Glyburide—ABCB1—bone marrow—breast cancer	6.73e-05	0.00154	CbGeAlD
Glyburide—ABCB1—female gonad—breast cancer	6.49e-05	0.00148	CbGeAlD
Glyburide—ABCB1—endocrine gland—breast cancer	6.03e-05	0.00138	CbGeAlD
Glyburide—Chlorpropamide—ABCB1—breast cancer	5.92e-05	0.0244	CrCbGaD
Glyburide—Vomiting—Vinorelbine—breast cancer	4.38e-05	0.000433	CcSEcCtD
Glyburide—Tremor—Capecitabine—breast cancer	4.37e-05	0.000432	CcSEcCtD
Glyburide—Rash—Vinorelbine—breast cancer	4.35e-05	0.00043	CcSEcCtD
Glyburide—Dermatitis—Vinorelbine—breast cancer	4.34e-05	0.000429	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—breast cancer	4.34e-05	0.000429	CcSEcCtD
Glyburide—Hypotension—Paclitaxel—breast cancer	4.33e-05	0.000428	CcSEcCtD
Glyburide—Urticaria—Fluorouracil—breast cancer	4.33e-05	0.000428	CcSEcCtD
Glyburide—Headache—Vinorelbine—breast cancer	4.32e-05	0.000427	CcSEcCtD
Glyburide—Leukopenia—Docetaxel—breast cancer	4.31e-05	0.000426	CcSEcCtD
Glyburide—Anaemia—Capecitabine—breast cancer	4.31e-05	0.000426	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—breast cancer	4.27e-05	0.000422	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—breast cancer	4.26e-05	0.000421	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—breast cancer	4.23e-05	0.000418	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Paclitaxel—breast cancer	4.23e-05	0.000418	CcSEcCtD
Glyburide—Hypersensitivity—Irinotecan—breast cancer	4.19e-05	0.000414	CcSEcCtD
Glyburide—Hypersensitivity—Mitoxantrone—breast cancer	4.19e-05	0.000414	CcSEcCtD
Glyburide—Vomiting—Thiotepa—breast cancer	4.19e-05	0.000414	CcSEcCtD
Glyburide—Leukopenia—Capecitabine—breast cancer	4.17e-05	0.000412	CcSEcCtD
Glyburide—Convulsion—Docetaxel—breast cancer	4.17e-05	0.000412	CcSEcCtD
Glyburide—ABCB1—lymph node—breast cancer	4.17e-05	0.000952	CbGeAlD
Glyburide—Paraesthesia—Paclitaxel—breast cancer	4.17e-05	0.000412	CcSEcCtD
Glyburide—Rash—Thiotepa—breast cancer	4.15e-05	0.00041	CcSEcCtD
Glyburide—Dermatitis—Thiotepa—breast cancer	4.15e-05	0.00041	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—breast cancer	4.15e-05	0.00041	CcSEcCtD
Glyburide—Dyspnoea—Paclitaxel—breast cancer	4.14e-05	0.000409	CcSEcCtD
Glyburide—Headache—Thiotepa—breast cancer	4.13e-05	0.000408	CcSEcCtD
Glyburide—Arthralgia—Docetaxel—breast cancer	4.1e-05	0.000405	CcSEcCtD
Glyburide—Myalgia—Docetaxel—breast cancer	4.1e-05	0.000405	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—breast cancer	4.1e-05	0.000405	CcSEcCtD
Glyburide—Nausea—Vinorelbine—breast cancer	4.1e-05	0.000405	CcSEcCtD
Glyburide—Dyspepsia—Paclitaxel—breast cancer	4.08e-05	0.000403	CcSEcCtD
Glyburide—Asthenia—Irinotecan—breast cancer	4.08e-05	0.000403	CcSEcCtD
Glyburide—Asthenia—Mitoxantrone—breast cancer	4.08e-05	0.000403	CcSEcCtD
Glyburide—Jaundice—Epirubicin—breast cancer	4.05e-05	0.0004	CcSEcCtD
Glyburide—Decreased appetite—Paclitaxel—breast cancer	4.03e-05	0.000398	CcSEcCtD
Glyburide—Hypersensitivity—Fluorouracil—breast cancer	4.01e-05	0.000397	CcSEcCtD
Glyburide—Gastrointestinal disorder—Paclitaxel—breast cancer	4e-05	0.000396	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—breast cancer	3.99e-05	0.000394	CcSEcCtD
Glyburide—Asthenia—Gemcitabine—breast cancer	3.97e-05	0.000393	CcSEcCtD
Glyburide—Myalgia—Capecitabine—breast cancer	3.97e-05	0.000392	CcSEcCtD
Glyburide—Arthralgia—Capecitabine—breast cancer	3.97e-05	0.000392	CcSEcCtD
Glyburide—Confusional state—Docetaxel—breast cancer	3.96e-05	0.000392	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—breast cancer	3.94e-05	0.000389	CcSEcCtD
Glyburide—Oedema—Docetaxel—breast cancer	3.93e-05	0.000388	CcSEcCtD
Glyburide—Pruritus—Gemcitabine—breast cancer	3.92e-05	0.000387	CcSEcCtD
Glyburide—Nausea—Thiotepa—breast cancer	3.91e-05	0.000387	CcSEcCtD
Glyburide—Diarrhoea—Irinotecan—breast cancer	3.89e-05	0.000384	CcSEcCtD
Glyburide—Diarrhoea—Mitoxantrone—breast cancer	3.89e-05	0.000384	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—breast cancer	3.88e-05	0.000383	CcSEcCtD
Glyburide—Shock—Docetaxel—breast cancer	3.87e-05	0.000382	CcSEcCtD
Glyburide—Nervous system disorder—Docetaxel—breast cancer	3.86e-05	0.000381	CcSEcCtD
Glyburide—Pruritus—Fluorouracil—breast cancer	3.85e-05	0.000381	CcSEcCtD
Glyburide—Thrombocytopenia—Docetaxel—breast cancer	3.85e-05	0.00038	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—breast cancer	3.84e-05	0.00038	CcSEcCtD
Glyburide—Confusional state—Capecitabine—breast cancer	3.84e-05	0.000379	CcSEcCtD
Glyburide—Feeling abnormal—Paclitaxel—breast cancer	3.82e-05	0.000378	CcSEcCtD
Glyburide—Oedema—Capecitabine—breast cancer	3.81e-05	0.000376	CcSEcCtD
Glyburide—Gastrointestinal pain—Paclitaxel—breast cancer	3.79e-05	0.000375	CcSEcCtD
Glyburide—Diarrhoea—Gemcitabine—breast cancer	3.79e-05	0.000375	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—breast cancer	3.75e-05	0.000371	CcSEcCtD
Glyburide—Anorexia—Docetaxel—breast cancer	3.75e-05	0.00037	CcSEcCtD
Glyburide—Shock—Capecitabine—breast cancer	3.75e-05	0.00037	CcSEcCtD
Glyburide—Nervous system disorder—Capecitabine—breast cancer	3.73e-05	0.000369	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—breast cancer	3.73e-05	0.000369	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—breast cancer	3.73e-05	0.000368	CcSEcCtD
Glyburide—Diarrhoea—Fluorouracil—breast cancer	3.73e-05	0.000368	CcSEcCtD
Glyburide—Thrombocytopenia—Capecitabine—breast cancer	3.73e-05	0.000368	CcSEcCtD
Glyburide—Urticaria—Paclitaxel—breast cancer	3.68e-05	0.000364	CcSEcCtD
Glyburide—Hyperhidrosis—Capecitabine—breast cancer	3.68e-05	0.000364	CcSEcCtD
Glyburide—Hypotension—Docetaxel—breast cancer	3.67e-05	0.000363	CcSEcCtD
Glyburide—Abdominal pain—Paclitaxel—breast cancer	3.67e-05	0.000362	CcSEcCtD
Glyburide—Anorexia—Capecitabine—breast cancer	3.63e-05	0.000358	CcSEcCtD
Glyburide—Vomiting—Irinotecan—breast cancer	3.62e-05	0.000357	CcSEcCtD
Glyburide—Vomiting—Mitoxantrone—breast cancer	3.62e-05	0.000357	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—breast cancer	3.6e-05	0.000355	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—breast cancer	3.59e-05	0.000355	CcSEcCtD
Glyburide—Rash—Mitoxantrone—breast cancer	3.59e-05	0.000354	CcSEcCtD
Glyburide—Rash—Irinotecan—breast cancer	3.59e-05	0.000354	CcSEcCtD
Glyburide—Dermatitis—Mitoxantrone—breast cancer	3.58e-05	0.000354	CcSEcCtD
Glyburide—Dermatitis—Irinotecan—breast cancer	3.58e-05	0.000354	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Docetaxel—breast cancer	3.58e-05	0.000354	CcSEcCtD
Glyburide—Headache—Mitoxantrone—breast cancer	3.56e-05	0.000352	CcSEcCtD
Glyburide—Headache—Irinotecan—breast cancer	3.56e-05	0.000352	CcSEcCtD
Glyburide—Hypotension—Capecitabine—breast cancer	3.56e-05	0.000351	CcSEcCtD
Glyburide—Paraesthesia—Docetaxel—breast cancer	3.53e-05	0.000349	CcSEcCtD
Glyburide—Alopecia—Methotrexate—breast cancer	3.52e-05	0.000348	CcSEcCtD
Glyburide—Vomiting—Gemcitabine—breast cancer	3.52e-05	0.000348	CcSEcCtD
Glyburide—Dyspnoea—Docetaxel—breast cancer	3.51e-05	0.000346	CcSEcCtD
Glyburide—Rash—Gemcitabine—breast cancer	3.49e-05	0.000345	CcSEcCtD
Glyburide—Dermatitis—Gemcitabine—breast cancer	3.49e-05	0.000345	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—breast cancer	3.49e-05	0.000345	CcSEcCtD
Glyburide—Erythema—Methotrexate—breast cancer	3.47e-05	0.000343	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—breast cancer	3.47e-05	0.000343	CcSEcCtD
Glyburide—Headache—Gemcitabine—breast cancer	3.47e-05	0.000343	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Capecitabine—breast cancer	3.47e-05	0.000343	CcSEcCtD
Glyburide—Vomiting—Fluorouracil—breast cancer	3.46e-05	0.000342	CcSEcCtD
Glyburide—Dyspepsia—Docetaxel—breast cancer	3.46e-05	0.000342	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—breast cancer	3.45e-05	0.000341	CcSEcCtD
Glyburide—Rash—Fluorouracil—breast cancer	3.43e-05	0.000339	CcSEcCtD
Glyburide—Dermatitis—Fluorouracil—breast cancer	3.43e-05	0.000339	CcSEcCtD
Glyburide—Paraesthesia—Capecitabine—breast cancer	3.42e-05	0.000338	CcSEcCtD
Glyburide—Decreased appetite—Docetaxel—breast cancer	3.42e-05	0.000338	CcSEcCtD
Glyburide—Hypersensitivity—Paclitaxel—breast cancer	3.42e-05	0.000338	CcSEcCtD
Glyburide—Headache—Fluorouracil—breast cancer	3.41e-05	0.000337	CcSEcCtD
Glyburide—Gastrointestinal disorder—Docetaxel—breast cancer	3.39e-05	0.000335	CcSEcCtD
Glyburide—Dyspnoea—Capecitabine—breast cancer	3.39e-05	0.000335	CcSEcCtD
Glyburide—Nausea—Mitoxantrone—breast cancer	3.38e-05	0.000334	CcSEcCtD
Glyburide—Nausea—Irinotecan—breast cancer	3.38e-05	0.000334	CcSEcCtD
Glyburide—Dyspepsia—Capecitabine—breast cancer	3.35e-05	0.000331	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—breast cancer	3.33e-05	0.000329	CcSEcCtD
Glyburide—Asthenia—Paclitaxel—breast cancer	3.33e-05	0.000329	CcSEcCtD
Glyburide—Decreased appetite—Capecitabine—breast cancer	3.31e-05	0.000327	CcSEcCtD
Glyburide—Alopecia—Epirubicin—breast cancer	3.3e-05	0.000326	CcSEcCtD
Glyburide—Nausea—Gemcitabine—breast cancer	3.29e-05	0.000325	CcSEcCtD
Glyburide—Gastrointestinal disorder—Capecitabine—breast cancer	3.29e-05	0.000325	CcSEcCtD
Glyburide—Pruritus—Paclitaxel—breast cancer	3.28e-05	0.000324	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—breast cancer	3.27e-05	0.000323	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—breast cancer	3.25e-05	0.000321	CcSEcCtD
Glyburide—Erythema—Epirubicin—breast cancer	3.25e-05	0.000321	CcSEcCtD
Glyburide—Feeling abnormal—Docetaxel—breast cancer	3.24e-05	0.00032	CcSEcCtD
Glyburide—Nausea—Fluorouracil—breast cancer	3.24e-05	0.00032	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—breast cancer	3.23e-05	0.000319	CcSEcCtD
Glyburide—Gastrointestinal pain—Docetaxel—breast cancer	3.21e-05	0.000318	CcSEcCtD
Glyburide—Anaemia—Methotrexate—breast cancer	3.21e-05	0.000317	CcSEcCtD
Glyburide—Diarrhoea—Paclitaxel—breast cancer	3.17e-05	0.000314	CcSEcCtD
Glyburide—Feeling abnormal—Capecitabine—breast cancer	3.14e-05	0.00031	CcSEcCtD
Glyburide—Gastrointestinal pain—Capecitabine—breast cancer	3.11e-05	0.000308	CcSEcCtD
Glyburide—Abdominal pain—Docetaxel—breast cancer	3.11e-05	0.000307	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—breast cancer	3.11e-05	0.000307	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—breast cancer	3.06e-05	0.000303	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—breast cancer	3.05e-05	0.000302	CcSEcCtD
Glyburide—Urticaria—Capecitabine—breast cancer	3.02e-05	0.000299	CcSEcCtD
Glyburide—Abdominal pain—Capecitabine—breast cancer	3.01e-05	0.000297	CcSEcCtD
Glyburide—Convulsion—Methotrexate—breast cancer	3.01e-05	0.000297	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—breast cancer	3.01e-05	0.000297	CcSEcCtD
Glyburide—Erythema—Doxorubicin—breast cancer	3.01e-05	0.000297	CcSEcCtD
Glyburide—Anaemia—Epirubicin—breast cancer	3e-05	0.000297	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—breast cancer	2.96e-05	0.000292	CcSEcCtD
Glyburide—Myalgia—Methotrexate—breast cancer	2.96e-05	0.000292	CcSEcCtD
Glyburide—Vomiting—Paclitaxel—breast cancer	2.95e-05	0.000291	CcSEcCtD
Glyburide—Rash—Paclitaxel—breast cancer	2.92e-05	0.000289	CcSEcCtD
Glyburide—Dermatitis—Paclitaxel—breast cancer	2.92e-05	0.000289	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—breast cancer	2.91e-05	0.000287	CcSEcCtD
Glyburide—Headache—Paclitaxel—breast cancer	2.91e-05	0.000287	CcSEcCtD
Glyburide—Hypersensitivity—Docetaxel—breast cancer	2.9e-05	0.000286	CcSEcCtD
Glyburide—Confusional state—Methotrexate—breast cancer	2.86e-05	0.000282	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—breast cancer	2.83e-05	0.00028	CcSEcCtD
Glyburide—Asthenia—Docetaxel—breast cancer	2.82e-05	0.000279	CcSEcCtD
Glyburide—Convulsion—Epirubicin—breast cancer	2.82e-05	0.000278	CcSEcCtD
Glyburide—Hypersensitivity—Capecitabine—breast cancer	2.8e-05	0.000277	CcSEcCtD
Glyburide—Pruritus—Docetaxel—breast cancer	2.78e-05	0.000275	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—breast cancer	2.78e-05	0.000275	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—breast cancer	2.78e-05	0.000275	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—breast cancer	2.77e-05	0.000274	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—breast cancer	2.77e-05	0.000273	CcSEcCtD
Glyburide—Myalgia—Epirubicin—breast cancer	2.77e-05	0.000273	CcSEcCtD
Glyburide—Nausea—Paclitaxel—breast cancer	2.76e-05	0.000272	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—breast cancer	2.74e-05	0.000271	CcSEcCtD
Glyburide—Asthenia—Capecitabine—breast cancer	2.73e-05	0.00027	CcSEcCtD
Glyburide—Anorexia—Methotrexate—breast cancer	2.7e-05	0.000267	CcSEcCtD
Glyburide—Pruritus—Capecitabine—breast cancer	2.69e-05	0.000266	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—breast cancer	2.69e-05	0.000266	CcSEcCtD
Glyburide—Diarrhoea—Docetaxel—breast cancer	2.69e-05	0.000266	CcSEcCtD
Glyburide—Confusional state—Epirubicin—breast cancer	2.67e-05	0.000264	CcSEcCtD
Glyburide—Oedema—Epirubicin—breast cancer	2.65e-05	0.000262	CcSEcCtD
Glyburide—Hypotension—Methotrexate—breast cancer	2.65e-05	0.000262	CcSEcCtD
Glyburide—Shock—Epirubicin—breast cancer	2.61e-05	0.000258	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—breast cancer	2.6e-05	0.000257	CcSEcCtD
Glyburide—Diarrhoea—Capecitabine—breast cancer	2.6e-05	0.000257	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—breast cancer	2.6e-05	0.000257	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—breast cancer	2.6e-05	0.000257	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—breast cancer	2.58e-05	0.000255	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—breast cancer	2.56e-05	0.000253	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—breast cancer	2.56e-05	0.000253	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—breast cancer	2.56e-05	0.000253	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—breast cancer	2.54e-05	0.000251	CcSEcCtD
Glyburide—Anorexia—Epirubicin—breast cancer	2.53e-05	0.00025	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—breast cancer	2.53e-05	0.00025	CcSEcCtD
Glyburide—Vomiting—Docetaxel—breast cancer	2.5e-05	0.000247	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—breast cancer	2.49e-05	0.000246	CcSEcCtD
Glyburide—Rash—Docetaxel—breast cancer	2.48e-05	0.000245	CcSEcCtD
Glyburide—Hypotension—Epirubicin—breast cancer	2.48e-05	0.000245	CcSEcCtD
Glyburide—Dermatitis—Docetaxel—breast cancer	2.48e-05	0.000245	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—breast cancer	2.47e-05	0.000244	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—breast cancer	2.46e-05	0.000243	CcSEcCtD
Glyburide—Headache—Docetaxel—breast cancer	2.46e-05	0.000243	CcSEcCtD
Glyburide—Oedema—Doxorubicin—breast cancer	2.45e-05	0.000242	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—breast cancer	2.45e-05	0.000242	CcSEcCtD
Glyburide—Vomiting—Capecitabine—breast cancer	2.42e-05	0.000239	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—breast cancer	2.42e-05	0.000239	CcSEcCtD
Glyburide—Shock—Doxorubicin—breast cancer	2.41e-05	0.000239	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—breast cancer	2.41e-05	0.000238	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—breast cancer	2.4e-05	0.000237	CcSEcCtD
Glyburide—Rash—Capecitabine—breast cancer	2.4e-05	0.000237	CcSEcCtD
Glyburide—Dermatitis—Capecitabine—breast cancer	2.4e-05	0.000237	CcSEcCtD
Glyburide—Headache—Capecitabine—breast cancer	2.38e-05	0.000236	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—breast cancer	2.38e-05	0.000235	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—breast cancer	2.37e-05	0.000234	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—breast cancer	2.36e-05	0.000234	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—breast cancer	2.34e-05	0.000231	CcSEcCtD
Glyburide—Nausea—Docetaxel—breast cancer	2.34e-05	0.000231	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—breast cancer	2.34e-05	0.000231	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—breast cancer	2.33e-05	0.000231	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—breast cancer	2.32e-05	0.000229	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—breast cancer	2.31e-05	0.000228	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—breast cancer	2.29e-05	0.000227	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—breast cancer	2.29e-05	0.000226	CcSEcCtD
Glyburide—Nausea—Capecitabine—breast cancer	2.26e-05	0.000223	CcSEcCtD
Glyburide—Urticaria—Methotrexate—breast cancer	2.25e-05	0.000222	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—breast cancer	2.24e-05	0.000221	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.24e-05	0.000221	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—breast cancer	2.2e-05	0.000218	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—breast cancer	2.19e-05	0.000216	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—breast cancer	2.19e-05	0.000216	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—breast cancer	2.17e-05	0.000214	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—breast cancer	2.16e-05	0.000213	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—breast cancer	2.13e-05	0.000211	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—breast cancer	2.12e-05	0.000209	CcSEcCtD
Glyburide—Urticaria—Epirubicin—breast cancer	2.11e-05	0.000208	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—breast cancer	2.1e-05	0.000207	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—breast cancer	2.09e-05	0.000206	CcSEcCtD
Glyburide—Asthenia—Methotrexate—breast cancer	2.03e-05	0.000201	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—breast cancer	2.02e-05	0.0002	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—breast cancer	2.01e-05	0.000198	CcSEcCtD
Glyburide—Pruritus—Methotrexate—breast cancer	2e-05	0.000198	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—breast cancer	1.95e-05	0.000193	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—breast cancer	1.95e-05	0.000193	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—breast cancer	1.94e-05	0.000192	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—breast cancer	1.94e-05	0.000192	CcSEcCtD
Glyburide—Asthenia—Epirubicin—breast cancer	1.9e-05	0.000188	CcSEcCtD
Glyburide—Pruritus—Epirubicin—breast cancer	1.88e-05	0.000185	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—breast cancer	1.81e-05	0.000179	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—breast cancer	1.81e-05	0.000179	CcSEcCtD
Glyburide—Vomiting—Methotrexate—breast cancer	1.8e-05	0.000178	CcSEcCtD
Glyburide—Rash—Methotrexate—breast cancer	1.79e-05	0.000177	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—breast cancer	1.79e-05	0.000176	CcSEcCtD
Glyburide—Headache—Methotrexate—breast cancer	1.78e-05	0.000175	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—breast cancer	1.76e-05	0.000174	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—breast cancer	1.74e-05	0.000172	CcSEcCtD
Glyburide—Vomiting—Epirubicin—breast cancer	1.69e-05	0.000167	CcSEcCtD
Glyburide—Nausea—Methotrexate—breast cancer	1.68e-05	0.000166	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—breast cancer	1.68e-05	0.000166	CcSEcCtD
Glyburide—Rash—Epirubicin—breast cancer	1.67e-05	0.000165	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—breast cancer	1.67e-05	0.000165	CcSEcCtD
Glyburide—Headache—Epirubicin—breast cancer	1.66e-05	0.000164	CcSEcCtD
Glyburide—Nausea—Epirubicin—breast cancer	1.58e-05	0.000156	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—breast cancer	1.56e-05	0.000154	CcSEcCtD
Glyburide—Rash—Doxorubicin—breast cancer	1.55e-05	0.000153	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—breast cancer	1.55e-05	0.000153	CcSEcCtD
Glyburide—Headache—Doxorubicin—breast cancer	1.54e-05	0.000152	CcSEcCtD
Glyburide—Nausea—Doxorubicin—breast cancer	1.46e-05	0.000144	CcSEcCtD
Glyburide—ABCC1—Metabolism—PIK3CD—breast cancer	1.4e-06	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.4e-06	1.6e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—BCHE—breast cancer	1.39e-06	1.6e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NCOA1—breast cancer	1.39e-06	1.6e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—breast cancer	1.38e-06	1.59e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC5A5—breast cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2D6—breast cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—STK11—breast cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP19A1—breast cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA4—breast cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CA9—breast cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1B—breast cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC2A1—breast cancer	1.36e-06	1.57e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NQO1—breast cancer	1.36e-06	1.57e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—breast cancer	1.35e-06	1.56e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOA2—breast cancer	1.35e-06	1.55e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—breast cancer	1.34e-06	1.55e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—breast cancer	1.34e-06	1.54e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA2—breast cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPX2—breast cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC2A1—breast cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NQO1—breast cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP3A4—breast cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.32e-06	1.52e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NOS3—breast cancer	1.32e-06	1.52e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SULT1A1—breast cancer	1.32e-06	1.51e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPX4—breast cancer	1.32e-06	1.51e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—breast cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—FASN—breast cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1B1—breast cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BCHE—breast cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP3A4—breast cancer	1.3e-06	1.49e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—breast cancer	1.29e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC5A5—breast cancer	1.29e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA1—breast cancer	1.29e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—IDH1—breast cancer	1.29e-06	1.48e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.28e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HSP90AA1—breast cancer	1.28e-06	1.47e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1B1—breast cancer	1.28e-06	1.47e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—COMT—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NAT2—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1A—breast cancer	1.26e-06	1.45e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—breast cancer	1.26e-06	1.45e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HSP90AA1—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—HMOX1—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NCOA1—breast cancer	1.25e-06	1.43e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ITPR1—breast cancer	1.25e-06	1.43e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC2A1—breast cancer	1.24e-06	1.43e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NQO1—breast cancer	1.24e-06	1.43e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—breast cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP19A1—breast cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—STK11—breast cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—breast cancer	1.22e-06	1.4e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.22e-06	1.4e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NCOA1—breast cancer	1.22e-06	1.4e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—breast cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—breast cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP3A4—breast cancer	1.21e-06	1.39e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—breast cancer	1.21e-06	1.39e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.21e-06	1.39e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK3—breast cancer	1.21e-06	1.39e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—STK11—breast cancer	1.2e-06	1.38e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP19A1—breast cancer	1.2e-06	1.38e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—breast cancer	1.2e-06	1.38e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1B1—breast cancer	1.19e-06	1.37e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMS—breast cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—breast cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—breast cancer	1.17e-06	1.34e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.17e-06	1.34e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—breast cancer	1.17e-06	1.34e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PLA2G4A—breast cancer	1.16e-06	1.34e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—breast cancer	1.16e-06	1.34e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NCOR1—breast cancer	1.16e-06	1.34e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NOS3—breast cancer	1.16e-06	1.34e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.15e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—COMT—breast cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—breast cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOA1—breast cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HMOX1—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—STK11—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP19A1—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ITPR1—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—DPYD—breast cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MED12—breast cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—COMT—breast cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GPX1—breast cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—breast cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1A1—breast cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALDOA—breast cancer	1.1e-06	1.26e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HMOX1—breast cancer	1.09e-06	1.26e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ERCC2—breast cancer	1.09e-06	1.26e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ITPR1—breast cancer	1.09e-06	1.25e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—breast cancer	1.08e-06	1.25e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—breast cancer	1.08e-06	1.24e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK3—breast cancer	1.07e-06	1.24e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—breast cancer	1.07e-06	1.23e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA3—breast cancer	1.07e-06	1.23e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—breast cancer	1.06e-06	1.22e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A2—breast cancer	1.06e-06	1.22e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMS—breast cancer	1.06e-06	1.21e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—breast cancer	1.05e-06	1.21e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.05e-06	1.21e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—breast cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NCOR1—breast cancer	1.04e-06	1.2e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.04e-06	1.2e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—breast cancer	1.04e-06	1.2e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—breast cancer	1.04e-06	1.2e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—COMT—breast cancer	1.04e-06	1.2e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTR—breast cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CPT1A—breast cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCG2—breast cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—breast cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMS—breast cancer	1.03e-06	1.19e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—breast cancer	1.03e-06	1.18e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—breast cancer	1.02e-06	1.18e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—breast cancer	1.02e-06	1.18e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HMOX1—breast cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ITPR1—breast cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PLA2G4A—breast cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—breast cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NCOR1—breast cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HPGDS—breast cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HBA1—breast cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GPX1—breast cancer	1e-06	1.15e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—breast cancer	9.95e-07	1.14e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—breast cancer	9.91e-07	1.14e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1A1—breast cancer	9.9e-07	1.14e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—breast cancer	9.89e-07	1.14e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTT1—breast cancer	9.86e-07	1.13e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ACHE—breast cancer	9.86e-07	1.13e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ERCC2—breast cancer	9.82e-07	1.13e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—breast cancer	9.81e-07	1.13e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GPX1—breast cancer	9.76e-07	1.12e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1A1—breast cancer	9.66e-07	1.11e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—breast cancer	9.66e-07	1.11e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMS—breast cancer	9.63e-07	1.11e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—breast cancer	9.63e-07	1.11e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ERCC2—breast cancer	9.58e-07	1.1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PLA2G4A—breast cancer	9.52e-07	1.09e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—breast cancer	9.52e-07	1.09e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOR1—breast cancer	9.52e-07	1.09e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—breast cancer	9.48e-07	1.09e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAV1—breast cancer	9.48e-07	1.09e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP17A1—breast cancer	9.33e-07	1.07e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—breast cancer	9.27e-07	1.07e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ENO1—breast cancer	9.24e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS1—breast cancer	9.24e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—breast cancer	9.23e-07	1.06e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—breast cancer	9.21e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GPX1—breast cancer	9.12e-07	1.05e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.06e-07	1.04e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2D6—breast cancer	9.06e-07	1.04e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1A1—breast cancer	9.03e-07	1.04e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—breast cancer	9.01e-07	1.04e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ERCC2—breast cancer	8.95e-07	1.03e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA2—breast cancer	8.89e-07	1.02e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—breast cancer	8.87e-07	1.02e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—breast cancer	8.64e-07	9.93e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—FASN—breast cancer	8.63e-07	9.92e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BCHE—breast cancer	8.59e-07	9.87e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAV1—breast cancer	8.51e-07	9.79e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A5—breast cancer	8.48e-07	9.75e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—breast cancer	8.42e-07	9.68e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAV1—breast cancer	8.31e-07	9.55e-06	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—breast cancer	8.26e-07	9.49e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—breast cancer	8.21e-07	9.44e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A1—breast cancer	8.19e-07	9.42e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NQO1—breast cancer	8.19e-07	9.42e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.13e-07	9.35e-06	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—breast cancer	8.13e-07	9.35e-06	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—breast cancer	8.08e-07	9.29e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—breast cancer	7.86e-07	9.03e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1B1—breast cancer	7.86e-07	9.03e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAV1—breast cancer	7.76e-07	8.92e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—breast cancer	7.75e-07	8.92e-06	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—breast cancer	7.75e-07	8.91e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HSP90AA1—breast cancer	7.7e-07	8.86e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—breast cancer	7.59e-07	8.73e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—breast cancer	7.57e-07	8.7e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA1—breast cancer	7.49e-07	8.62e-06	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—breast cancer	7.43e-07	8.54e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.42e-07	8.53e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP19A1—breast cancer	7.39e-07	8.49e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—STK11—breast cancer	7.39e-07	8.49e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—breast cancer	7.25e-07	8.33e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—NOS3—breast cancer	7.17e-07	8.24e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—breast cancer	7.07e-07	8.13e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—COMT—breast cancer	6.87e-07	7.89e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—breast cancer	6.83e-07	7.86e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—breast cancer	6.82e-07	7.84e-06	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—breast cancer	6.75e-07	7.76e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMOX1—breast cancer	6.74e-07	7.75e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—breast cancer	6.73e-07	7.74e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ITPR1—breast cancer	6.72e-07	7.73e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—breast cancer	6.65e-07	7.65e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—breast cancer	6.62e-07	7.61e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—breast cancer	6.57e-07	7.55e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—breast cancer	6.56e-07	7.54e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—breast cancer	6.54e-07	7.52e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—breast cancer	6.47e-07	7.44e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NOS3—breast cancer	6.44e-07	7.4e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMS—breast cancer	6.35e-07	7.3e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NOS3—breast cancer	6.28e-07	7.22e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOR1—breast cancer	6.28e-07	7.22e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—breast cancer	6.28e-07	7.22e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PLA2G4A—breast cancer	6.28e-07	7.22e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—breast cancer	6.22e-07	7.15e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—breast cancer	6.14e-07	7.05e-06	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—breast cancer	6.07e-07	6.98e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPX1—breast cancer	6.01e-07	6.91e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1A1—breast cancer	5.95e-07	6.84e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—breast cancer	5.94e-07	6.83e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ERCC2—breast cancer	5.9e-07	6.79e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—breast cancer	5.89e-07	6.77e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NOS3—breast cancer	5.87e-07	6.75e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—breast cancer	5.8e-07	6.67e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—breast cancer	5.75e-07	6.61e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—breast cancer	5.72e-07	6.58e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—breast cancer	5.55e-07	6.38e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—breast cancer	5.42e-07	6.23e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—breast cancer	5.37e-07	6.17e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—breast cancer	5.34e-07	6.14e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—breast cancer	5.13e-07	5.9e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAV1—breast cancer	5.12e-07	5.89e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—breast cancer	5.01e-07	5.76e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—breast cancer	4.68e-07	5.38e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—breast cancer	4.66e-07	5.36e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—breast cancer	4.1e-07	4.71e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—breast cancer	4.05e-07	4.65e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—breast cancer	4.04e-07	4.64e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NOS3—breast cancer	3.87e-07	4.45e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—breast cancer	3.62e-07	4.16e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—breast cancer	3.57e-07	4.11e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—breast cancer	3.54e-07	4.07e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—breast cancer	3.54e-07	4.06e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—breast cancer	3.3e-07	3.8e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—breast cancer	3.3e-07	3.79e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—breast cancer	3.09e-07	3.55e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—breast cancer	2.96e-07	3.4e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—breast cancer	2.89e-07	3.32e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—breast cancer	2.7e-07	3.1e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—breast cancer	2.18e-07	2.5e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—breast cancer	1.78e-07	2.05e-06	CbGpPWpGaD
